Periodic Reporting for period 1 - G2B-002 (GATE2BRAIN TOWARDS SME DESIGNATION AND PAEDIATRIC INVESTIGATIONAL PLAN)

Gate2Brain is a pioneering biotech company focused on developing therapeutics capable of efficiently crossing biological barriers, such as the blood-brain barrier (BBB). Utilizing a cutting-edge peptide-based patented technology platform, Gate2Brain has developed G2B-002, a...